Comparing the Efficacy and Safety of Natalizumab and Ocrelizumab in Patients with Relapsing-Remitting Multiple Sclerosis and Spinal Lesions

被引：0
|
作者：
Huntemann, Niklas [1 ,2 ]
Mueller, Marc [1 ,2 ]
Masanneck, Lars [1 ,2 ]
Baumgart, Romy [3 ]
Axhausen, Franziska [3 ]
Wolff, Stephanie [3 ]
Kutsojannis, Bela [1 ,2 ]
Koelsche, Tristan [1 ,2 ]
Korsen, Melanie [1 ,2 ]
Pfeuffer, Steffen [3 ]
Meuth, Sven [1 ,2 ]
Pawlitzki, Marc [1 ,2 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Neurol, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dusseldorf, Germany
[3] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, Dept Neurol, Giessen, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O095/1249
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis: week 96 results of a phase II, randomised, multicentre trial
    Kappos, L.
    Li, D.
    Calabresi, P.
    O'Connor, P.
    Bar-Or, A.
    Barkhof, F.
    Yin, M.
    Leppert, D.
    Glanzmann, R.
    Tinbergen, J.
    Hauser, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S194 - S195
  • [42] Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
    Havrdova, Eva
    Galetta, Steven
    Hutchinson, Michael
    Stefoski, Dusan
    Bates, David
    Polman, Chris H.
    O'Connor, Paul W.
    Giovannoni, Gavin
    Phillips, J. Theodore
    Lublin, Fred D.
    Pace, Amy
    Kim, Richard
    Hyde, Robert
    LANCET NEUROLOGY, 2009, 8 (03): : 254 - 260
  • [43] Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis
    Meuth, Sven G.
    Bittner, Stefan
    Seiler, Carola
    Goebel, Kerstin
    Wiendl, Heinz
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (02) : 198 - 203
  • [44] COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN RUSSIA
    Matveev, N., V
    Sabanov, A., V
    Luneva, A., V
    VALUE IN HEALTH, 2014, 17 (03) : A60 - A60
  • [45] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [46] Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis
    Bittner, S.
    Meuth, S.
    Seiler, C.
    Reiners, K.
    Wiendl, H.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S247 - S247
  • [47] Efficacy of natalizumab and fingolimod in relapsing-remitting multiple sclerosis in real world clinical practice
    Totaro, R.
    Costantino, G.
    Bellantonio, P.
    Danni, M.
    Di Carmine, C.
    Fantozzi, R.
    Cerqua, R.
    Fuiani, A.
    Mundi, C.
    Ruggieri, S.
    Marini, C.
    Provinciali, L.
    Carolei, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 267 - 267
  • [48] Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the TYSABRI® Observational Programme in Canada
    Jacques, F.
    Bhan, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 695 - 696
  • [49] EFFICACY AND SAFETY OF NATALIZUMAB TREATMENT FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: INTERIM RESULTS OF THE TYSABRI® OBSERVATIONAL PROGRAMME IN THE UK
    Hanna, Jerome
    Rosen, Jan Paul
    Smethurst, Caroline
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [50] Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients
    van Lierop, Z. Y. G. J.
    Toorop, A. A.
    Coerver, E. M. E.
    Willemse, E. A. J.
    Strijbis, E. M. M.
    Kalkers, N. F.
    Moraal, B.
    Barkhof, F.
    Teunissen, C. E.
    Killestein, J.
    van Kempen, Z. L. E.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
12345